BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34897998)

  • 1. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
    Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
    Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?
    Wang Y; Niu K; Shi Y; Zhou F; Li X; Li Y; Chen T; Zhang Y
    Int J Surg; 2024 May; ():. PubMed ID: 38701508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability.
    Tsai JM; Aguirre JD; Li YD; Brown J; Focht V; Kater L; Kempf G; Sandoval B; Schmitt S; Rutter JC; Galli P; Sandate CR; Cutler JA; Zou C; Donovan KA; Lumpkin RJ; Cavadini S; Park PMC; Sievers Q; Hatton C; Ener E; Regalado BD; Sperling MT; Słabicki M; Kim J; Zon R; Zhang Z; Miller PG; Belizaire R; Sperling AS; Fischer ES; Irizarry R; Armstrong SA; Thomä NH; Ebert BL
    Mol Cell; 2023 Aug; 83(15):2753-2767.e10. PubMed ID: 37478846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orphan quality control shapes network dynamics and gene expression.
    Mark KG; Kolla S; Aguirre JD; Garshott DM; Schmitt S; Haakonsen DL; Xu C; Kater L; Kempf G; Martínez-González B; Akopian D; See SK; Thomä NH; Rapé M
    Cell; 2023 Aug; 186(16):3460-3475.e23. PubMed ID: 37478862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing UBR5 for targeted protein degradation of key transcriptional regulators.
    Taherbhoy AM; Daniels DL
    Trends Pharmacol Sci; 2023 Nov; 44(11):758-761. PubMed ID: 37770316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of concern: MRE11 and UBR5 co-operate to suppress RNF168-mediated fusion of dysfunctional telomeres.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1308554. PubMed ID: 38144537
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative proteomic profiling of uric acid, ammonium acid urate, and calcium-based kidney stones.
    Khusid JA; Vasquez A; Sadiq AS; Stockert JA; Gallante B; Yaghoubian A; Shimonov R; Stock A; Atallah W; Kyprianou N; Yang W; Gupta M
    Am J Clin Exp Urol; 2023; 11(3):265-274. PubMed ID: 37441444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of UBR5 in tumor proliferation and oncotherapy.
    Hu B; Chen S
    Gene; 2024 May; 906():148258. PubMed ID: 38331119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
    Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
    Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
    Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
    J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
    Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
    Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
    Shearer RF; Iconomou M; Watts CK; Saunders DN
    Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
    Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
    J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.